Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: A single centre experience

International Journal of Cardiology

Volumn 116, Issue 2, 2007, Pages 167-173

  Soriano, Carlos J ^a   Ridocci, Francisco ^a   Estornell, Jordi ^b   Pérez Boscá, José L ^a   Pomar, Francisco ^a   Trigo, Alberto ^a   Planas, Ana ^a   Nadal, Mercedes ^a   Jacas, Victoria ^a   Martinez, Vicente ^b   Paya, Rafael ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b Hospital General Universitario Avda   (Spain)

Author keywords

Cardiovascular magnetic resonance; Heart failure; Ischemic cardiomyopathy

Indexed keywords

GADOLINIUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

AGED; CARDIAC OUTPUT, LOW; CARDIOVASCULAR SYSTEM; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; ENDOCARDIUM; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33846983557     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.03.040     Document Type: Article

References (46)

1. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
2. Remme W.J., and Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Eur Heart J 22 (2001) 1527-1560
3. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of The American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). 2001. American College of Cardiology Web Site. Available at:http://www.acc.org/clinical/guidelines/failure/hf_index.htm. (Accesed march 2005).
4. Gunnarsson G., Eriksson P., and Dellborg M. ECG criteria in diagnosis of acute myocardial infarction in the presence of left bundle branch block. Int J Cardiol 78 (2001) 167-174
5. Bart B.A., Shaw L.K., McCants Jr. C.B., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30 (1997) 1002-1008
6. Felker G.M., Shaw L.K., and O'Connor C.M. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39 (2002) 210-218
7. Bashore T.M., Bates E.R., Berger P.B., et al. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 2170-2214
8. McCrohon J.A., Moon J.C., Prasad S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 (2003) 54-59
9. Soriano C.J., Ridocci F., Estornell J., Jiménez J., Martinez V., and De Velasco J.A. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 45 (2005) 743-748
10. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A Statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
11. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
12. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000) 570-580
13. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
14. Bello D., Shah D.J., Farah G.M., et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy. Circulation 108 (2003) 1945-1953
15. Diaz R.A., Nihoyannopoulos P., Athanassopoulos G., and Oakley C.M. Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure. Am J Cardiol 68 (1991) 1224-1227
16. Sawada S.G., Ryan T., Segar D., et al. Distinguishing ischemic cardiomyopathy from nonischemic dilated cardiomyopathy with coronary echocardiography. J Am Coll Cardiol 19 (1992) 1223-1228
17. Sharp S.M., Sawada S.G., Segar D.S., et al. Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol 24 (1994) 934-939
18. Vigna C., Russo A., De Rito V., et al. Regional wall motion analysis by dobutamine stess echocardiography to distinguish between ischemic and nonischemic dilated cardiomyopathy. Am Heart J 131 (1996) 537-543
19. Cohen A., Chauvel C., Benhalima B., Guyon P., Desert I., and Valty J. Is dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy?. Angiology 48 (1997) 783-793
20. Senior R., Janardhanan R., Jeetley P., and Burden L. Myocardial contrast echocardiography for distinguishing ischemic from nonischemic first-onset acute heart failure: insights into the mechanism of acute heart failure. Circulation 112 (2005) 1587-1593
21. Wallis D.E., O'Connell J.B., Henkin R.E., Costanzo-Nordin M.R., and Scanlon P.J. Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign. J Am Coll Cardiol 4 (1984) 674-679
22. Glamann D.B., Lange R.A., Corbett J.R., and Hillis L.D. Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy. Arch Intern Med 152 (1992) 769-772
23. Iskandrian A.S., Hakki A.H., and Kane S. Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: differences between patients with primary cardiomyopathy, chronic coronary artery disease, or acute myocardial infarction. Am Heart J 111 (1986) 760-767
24. Chikamori T., Doi Y.L., Yonezawa Y., Yamada M., Seo H., and Ozawa T. Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. Am J Cardiol 69 (1992) 650-653
25. Tauberg S.G., Orie J.E., Bartlett B.E., Cottington E.M., and Flores A.R. Usefulness of thallium-201 for distinction of ischemic from idiopathic dilated cardiomyopathy. Am J Cardiol 71 (1993) 674-680
26. Danias P.G., Papaioannou G.I., Ahlberg A.W., et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol 94 (2004) 14-19
27. Eisenberg J.D., Sobel B.E., and Geltman E.M. Differentiation of ischemic from nonischemic cardiomyopathy with positron emission tomography. Am J Cardiol 59 (1987) 1410-1414
28. Mody F.V., Brunken R.C., Stevenson L.W., Nienaber C.A., Phelps M.E., and Schelbert H.R. Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J Am Coll Cardiol 17 (1991) 373-383
29. Budoff M.J., Shavelle D.M., Lamont D.H., et al. Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy. J Am Coll Cardiol 32 (1998) 1173-1178
30. Braunwald E., and Pfeffer M.A. Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. Am J Cardiol 68 (1991) 1D-6D
31. Velazquez E.J., Francis G.S., Armstrong P.W., et al. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. Eur Heart J 25 (2004) 1911-1919
32. Ambrosio G., Betocchi S., Pace L., et al. Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease. Circulation 94 (1996) 2455-2464
33. Elsasser A., Schelepper M., Klovekorn W.P., et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 96 (1997) 2920-2931
34. Rahimtoola S.H. Concept and evaluation of hibernating myocardium. Annu Rev Med 50 (1999) 75-86
35. Luscher T.F., Boulanger C.M., Dohi Y., and Yang Z.H. Endothelium-derived contracting factors. Hypertension 19 (1992) 117-130
36. Paulus W.J., Vantrimpont P.J., and Shah A.M. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 92 (1995) 2119-2126
37. Kelly R.A., Balligand J.L., and Smith T.W. Nitric oxide and cardiac function. Circ Res 79 (1996) 363-380
38. Anderson L.J., Holden S., Davies B., et al. Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22 (2001) 2171-2179
39. Wilson J.M., Villareal R.P., Hariharan R., Massumi A., Muthupillai R., and Flamm S.D. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J 29 (2002) 176-180
40. Choudhury L., Mahrholdt H., Wafner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
41. Moon J.C.C., Mundy H.R., Lee P.J., Mohiaddin R.H., and Pennell D.J. Myocardial fibrosis in glycogen storage disease type 3. Circulation 107 (2003) e47
42. Moon J.C.C., McKenna W.J., McCrohon J.A., Elliot P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
43. Moon J.C.C., Sachdev B., Elkington A.G., et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease (1). Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24 (2003) 2151-2155
44. Moon J.C.C., Reed E., Sheppard M.N., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264
45. Mahrholdt H., Goedecke C., Wagner A., et al. Cardiovascular magnetic resonance assessment of human myocarditis. Comparison to histology and molecular pathology. Circulation 109 (2004) 1250-1258
46. Maceira A.M., Joshi J., Prasad S.K., et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 18 (2005) 186-193